Helicobacterpylori resistance rates for levofloxacin, tetracycline and rifabutin among Irish isolates at a reference centre

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Irish Journal of Medical Science

• Publication date

  2013-04-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11845-013-0957-3PMID 23625165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of Helicobacter pylori Infection 2015

  2015cited by this paper
• Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

  2012cited by this paper
• Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain.

  2012cited by this paper
• European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.

  2011cited by this paper
• European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009).

  2011cited by this paper
• European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009).

  2011cited by this paper
• Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.

  2011cited by this paper
• Clinical trial: clarithromycin vs. levofloxacin in first‐line triple and sequential regimens for Helicobacter pylori eradication

  2010cited by this paper
• High Level of Antimicrobial Resistance in French Helicobacter pylori Isolates

  2010cited by this paper
• Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland

  2010cited by this paper
• Worldwide H. pylori antibiotic resistance: a systematic review.

  2010cited by this paper
• Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK.

  2009cited by this paper
• Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing „Concomitant Therapy“ Versus Triple Therapy for Helicobacter pylori Eradication

  2009cited by this paper
• Prevalence of Primary Fluoroquinolone Resistance Among Clinical Isolates of Helicobacter pylori at a University Hospital in Southern Taiwan

  2009cited by this paper
• Meta‐analysis: Four‐Drug, Three‐Antibiotic, Non‐bismuth‐Containing “Concomitant Therapy” Versus Triple Therapy for Helicobacter pylori Eradication

  2009cited by this paper
• Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer?

  2009cited by this paper
• Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients

  2008cited by this paper
• Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000-2005).

  2007cited by this paper
• The effectiveness of rifabutin triple therapy for patients with difficult‐to‐eradicate Helicobacter pylori in clinical practice

  2007cited by this paper
• American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection

  2007cited by this paper
• Quinolone Resistance in Helicobacter pylori Isolates in Germany

  2006cited by this paper
• Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

  2006cited by this paper
• Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.

  2006cited by this paper
• Treatment of Helicobacter pylori Infection

  2006cited by this paper
• New once‐daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study

  2005cited by this paper
• Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.

  2001cited by this paper
• Re-treatment after Helicobacter pylori eradication failure.

  1999cited by this paper
• Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study

  1996cited by this paper

• Levofloxacin+Tetracycline Quadruple Regimen for Eradication of Helicobacter pylori: A Multicenter Multinational Randomized Controlled Trial

  2023cites this paper
• Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori

  2020influential citation
• Rifabutin for the Treatment of Helicobacter pylori Infection: A Review

  2020cites this paper
• Gastric Microbiota and Resistance to Antibiotics Gastric Microbiota and Resistance to Antibiotics

  2019cites this paper
• Evaluation of diagnostic and treatment strategies for the management of Helicobacter pylori infection

  2019influential citation
• Gastric Microbiota and Resistance to Antibiotics

  2018cites this paper
• Gastric Microbiota and Resistance to Antibiotics

  2018cites this paper
• Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.

  2018cites this paper
• Can bacterial virulence factors predict antibiotic resistant Helicobacter pylori infection?

  2018cites this paper
• Letter: levofloxacin resistance – a challenge for the treatment of Helicobacter pylori infection

  2017cites this paper
• The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.

  2017cites this paper
• Regional Antibiotic Resistance of Helicobacter pylori

  2016cites this paper
• Loop‐Mediated Isothermal Amplification as a Fast Noninvasive Method of Helicobacter pylori Diagnosis

  2016cites this paper
• Eradication of Helicobacter Pylori Infection: Past, Present and Future

  2016cites this paper
• The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.

  2016cites this paper
• Management of H. pylori Infection in Europe

  2016cites this paper
• Мониторинг первичной антибиотикорезистентности штаммов Helicobacter pylori, выделенных в республике Татарстан в 2008-2013 гг

  2016cites this paper
• Review: Clinical Management of Helicobacter pylori Infection in China

  2015cites this paper
• Rescue Therapy with a Proton Pump Inhibitor Plus Amoxicillin and Rifabutin for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis

  2015cites this paper
• Antibiotic treatment for Helicobacter pylori: Is the end coming?

  2015cites this paper
• Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy.

  2015cites this paper
• Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review.

  2015cites this paper
• Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland.

  2015cites this paper
• Quinolone-based first, second and third-line therapies for Helicobacter pylori

  2015cites this paper
• Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.

  2014cites this paper
• Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.

  2014cites this paper
• Fluoroquinolone-based protocols for eradication of Helicobacter pylori.

  2014cites this paper
• Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials

  2014cites this paper
• Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy

  2014cites this paper
• Treatment of Helicobacter pylori Infection 2014

  2014cites this paper
• Quadruple rescue therapy after first and second line failure for Helicobacter pylori treatment: comparison between two tetracycline-based regimens.

  2014cites this paper
• Membrane-lipids anti-bacterial and anti-tumoral therapies revisited: an example with Helicobacter pylori infection

  2013cites this paper
• Treatment of Helicobacter pylori Infection 2013

  2013cites this paper
• How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

  2013cites this paper